Stock listing
4547 Stock Price, News, Filings & Events — Kissei Pharmaceutical Co., Ltd.
Selected listing: 4547 · TSE · JPY · JP
This page tracks Kissei Pharmaceutical Co., Ltd.'s 4547:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4547:TSE. 4547:TSE is the stock-level entry point for investors researching Kissei Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kissei Pharmaceutical Co., Ltd. is a publicly traded company on the Japanese market under the ticker 4547. The company has a market capitalization of approximately 1.05 billion USD. Kissei focuses on the development and commercialization of innovative pharmaceutical products.
- Ticker
- 4547:TSE
- Asset type
- Stock
- Market cap
- $1.05B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSE
- Currency
- JPY
Kissei Pharmaceutical Co., Ltd. 4547:TSE stock context
This page tracks Kissei Pharmaceutical Co., Ltd.'s 4547:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4547:TSE. 4547:TSE is the stock-level entry point for investors researching Kissei Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kissei Pharmaceutical Co., Ltd. is a publicly traded company on the Japanese market under the ticker 4547. The company has a market capitalization of approximately 1.05 billion USD. Kissei focuses on the development and commercialization of innovative pharmaceutical products.
Latest news from Kissei Pharmaceutical Co., Ltd.
Notice of Completion of Payment for Treasury Shares Disposal as Restricted Stock for Employee Shareholding Association and Partial
August 10, 2026
Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]
July 31, 2026
Notice Regarding Completion of Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers
July 23, 2026
Announcement for the Opnion by European Authorities on TAVNEOS
June 28, 2026
Notice Concerning Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers
June 23, 2026
Research Kissei Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd. investor report
Review AI stock analysis and investor report context for 4547:TSE.
Kissei Pharmaceutical Co., Ltd. company profile
View the public company page for Kissei Pharmaceutical Co., Ltd. on 6ix.
Kissei Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Kissei Pharmaceutical Co., Ltd..
Kissei Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Kissei Pharmaceutical Co., Ltd..